FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/11/010607 [Registered on: 23/11/2017] Trial Registered Prospectively
Last Modified On: 22/11/2017
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparing Visual Outcomes for cylindrical power correction using 2 advanced techniques for laser vision correction : LASIK & SMILE 
Scientific Title of Study   Comparing Visual Outcomes of Topo Guided LASIK with Small Incision Lenticule Extraction (SMILE) in eyes with Astigmatism: A prospective contralateral eye study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  D Ramamurthy 
Designation  Chairman 
Affiliation  The Eye Foundation 
Address  The Eye Foundation 582 A, DB Road RS Puram Coimbatore.

Coimbatore
TAMIL NADU
641002
India 
Phone  9894231663  
Fax    
Email  drramamurthy@theeyefoundation.com  
 
Details of Contact Person
Scientific Query
 
Name  Shreyas Ramamurthy 
Designation  Consultant, The Eye Foundation 
Affiliation  The Eye Foundation  
Address  The Eye Foundation 582 A, DB Road RS Puram Coimbatore

Coimbatore
TAMIL NADU
641002
India 
Phone  9894231663  
Fax    
Email  shreyas@theeyefoundation.com  
 
Details of Contact Person
Public Query
 
Name  Shreyas Ramamurthy 
Designation  Consultant, The Eye Foundation 
Affiliation  The Eye Foundation  
Address  The Eye Foundation 582 A, DB Road RS Puram Coimbatore

Coimbatore
TAMIL NADU
641002
India 
Phone  9894231663  
Fax    
Email  shreyas@theeyefoundation.com  
 
Source of Monetary or Material Support  
Alcon Laboratories (India) Private Limited Crescent 4, 3rd Floor, Prestige Shantiniketan Tower 2 Whitefield Road, Bangalore 560048  
 
Primary Sponsor  
Name  DrDRamamurthy 
Address  The Eye Foundation, 582A, D.B.Road, R.S.Puram, Coimbatore.  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrDRamamurthy  The Eye Foundation  582A DB Road, RS Puram Coimbatore
Coimbatore
TAMIL NADU 
9443317791

drramamurthy@theeyefoundation.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
TheEyeFoundationEthicsCommittee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Approved/Obtained 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Patients with compound myopic astigmatism wanting to undergo refractive surgery,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Contoura Guided Laser Assisted Insitu Keratomileusis(LASIK)  Comparing Visual Outcomes of Topo Guided LASIK with Small Incision Lenticule Extraction (SMILE) in eyes with Astigmatism: A prospective contralateral eye study 
Comparator Agent  Small Incision Lenticule Extraction (SMILE)  Comparing Visual Outcomes of Topo Guided LASIK with Small Incision Lenticule Extraction (SMILE) in eyes with Astigmatism: A prospective contralateral eye study 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  1. Subjects 18 years of age or older.
2. Myopia requiring (a) refractive error correction of -0.5 to -8.0 manifest refraction sphere with (b) astigmatism correction of -1.0 D to -5.0Dmanifestrefraction cylinder
3. Intended treatment is targeted for emmetropia.
4. Pre-surgery BCVA of 0 logarithm of the minimum angle of resolution (logMAR) (20/20) or better.
5. Willing and able to complete all post-surgery visits.
 
 
ExclusionCriteria 
Details  1. Pregnancy or lactation, current or planned, during the course of the study.
2. Mixed astigmatism refractive error.
3. Degenerations of structure of the cornea including diagnosed keratoconus, formefrustekerataconus or pellucid marginal degeneration.
4. History or evidence of active or inactive corneal or other anterior segment disease (e.g, herpes simplex keratitis, recurrent erosionsyndrome).
5. Weakened immune system, including diagnosed collagen vascular, autoimmune or immunodeficiency disease.
6. Co existing Retinal or Optic nerve head co morbidities which could affect the final visual outcome.
 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Not Applicable 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
The primary objective of the study is to evaluate percentage of eyes with manifest refraction cylinder ≤ 0.5 D at 3 months using the two techniques.  The primary objective of the study is to evaluate percentage of eyes with manifest refraction cylinder ≤ 0.5 D at 3 months using the two techniques. 
 
Secondary Outcome  
Outcome  TimePoints 
1. Mean refractive cylinder at 3 months
2. Percentage of eyes with atleast 1 line gain in BCVA at 3 months
3. Percentage of eyes with UCVA of 20/20 or better at 3 months

 
3 months 
 
Target Sample Size   Total Sample Size="138"
Sample Size from India="138" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   01/12/2017 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

Overview

 

Laser in situ keratomileusis (LASIK), a refractive surgery procedure, has been in vogue for over 2 decades for the correction of refractive error. The refractive error correction is achieved by the ablation of the required amount of corneal stromal tissue by an excimer laser.

TheWaveLight®EX500 excimer laser system is the most recent Alcon excimerlaser. Treatment planning for LASIK is done with the refractive error correction data and with orwithout other patient specific pre-surgical data. Wavefront guided or Wavefront optimized has been the main method of laser refractive correction. In recent years interest in Topography Guided LASIK has developed as a modality of treatment and has been used primarily for the treatment of irregular ordiseased corneas that either had never been treated or had been previously treated

 

More recently, Topography Guided LASIK is being used as a primary treatment for regular corneas. A study by Stultinget. al showed thatTopography Guided LASIK as a primary treatment for myopia with or without astigmatismwas safe and effective in subjects who had regular corneas (Stulting 2016). The advantage that a topography guided treatment has over wavefront treatment is that it has more static and reproducible data with collection of more data points from the peripheral cornea thereby enabling the creation of a smoother and more customized ablation profile.

Small incision lenticular extraction (SMILE) is the newest refractive surgery procedure thatis being used for the correction of myopia with or without astigmatism. The Zeiss VisuMaxsurgical laser, a femtosecond laser, is the only marketed laser for the SMILE procedure. The VisuMax creates a lenticule of corneal tissue and a small (<4mm)channel through which the lenticule is removed. The removal of the lenticule results incorrection of the refractive error.

Fundamental difference between the EX500 and VisuMax are that the EX500 provides centration and cyclotorsion control, and the VisuMax does not. Centration and cyclotorsioncontrol allow for better correction of astigmatism. Additionally, use of the topography datafor treatment planning of Topography Guided data should allow for better correction ofastigmatism compared to SMILE for which topography data is not used for treatmentplanning.

HYPOTHESIS

This study is designed to test the differences in astigmatism treatment between TopographyGuided LASIK and SMILE. The difference in astigmatism treatment between the two refractive surgeries is hypothesized to be related to the differences in the lasers and treatment planning.

With Topography Guided LASIK, the cyclotorsion control and the centrationfeatures of the EX500 laser and the use of topography data for treatment planning should enhance the accuracy of astigmatism treatment. In contrast, with SMILE, the VisuMaxLaserkeratome does not have cyclotorsion control or centration nor is topography data used for treatment planning.

This contralateral eye study performed in eyes with astigmatism >1D would enable an effective comparison of the efficacy of the two techniques in correction of astigmatism. 

Purpose: The purpose of the study is to compare the visual outcomes of Topoguided Lasik with SMILE performed in contralateral eyes with Myopic astigmatism.

Material & Methods:

Eyes which meet the inclusion criteria to undergo baseline screening procedures including cycloplegicrefracton, Pentacam Tomography, Aberrometry, Pupillometry, Dry Eye Work up & Axial length measurements, Corneal Biomechanics measurements using Corvis  within a period of 1 month from the procedure.

The patients will be randomized to undergo topoguided LASIK in one eye & SMILE in the contralateral eye. All patients will undergo bilateral treatment for contralateral eye comparison.

Follow up visits: Day 1, 1 week, 1 month, 3 months & 1 year.

Outcome Parameters:

1.Primary: Percentage of eyes with residual cylinder >0.5D at 3 months.

Secondary:

1.Percentage of eyes with atleast 1 line gain in BCVA at 3 months

2.Percentage of eyes with UCVA of 20/20 or better at 3 months

3. To evaluate Induction of Higher Order Aberrations post procedure

4. To assess Quality of Vision & Vision related Quality of life through Questionnaire post procedure

 

 
Close